Evidence map›Paper›PMID 37586390›Full record

ArticleThe lancet. HIV2023

Trends in HIV prevalence, incidence, and progress towards the UNAIDS 95-95-95 targets in Malawi among individuals aged 15-64 years: population-based HIV impact assessments, 2015-16 and 2020-21.

Danielle Payne, Nellie Wadonda-Kabondo, Alice Wang, Joshua Smith-Sreen, Alinune Kabaghe, George Bello, Felix Kayigamba, Lyson Tenthani, Alice Maida, Andrew Auld and 12 more

Abstract read
In one paragraph

Article in The lancet. HIV, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Dementia prevalence and risk factors in people with and without HIV in Malawi: A medical record review.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Danielle PayneUS Centers for Disease Control and Prevention, Lilongwe, Malawi. Electronic address: ywb9@cdc.gov.
Nellie Wadonda-KabondoUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Alice WangUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Joshua Smith-SreenUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Alinune KabagheUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
George BelloInternational Training and Education Center for Health, Lilongwe, Malawi.
Felix KayigambaICAP, Lilongwe, Malawi.
Lyson TenthaniICAP, Lilongwe, Malawi.
Alice MaidaUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Andrew AuldUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Andrew C VoetschUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Sasi JonnalagaddaUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Kristin BrownUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Christine A WestUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Evelyn KimUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Francis OgollahICAP, Lilongwe, Malawi.
Mansoor FarahaniICAP, New York, NY, USA.
Trudy DobbsUS Centers for Disease Control and Prevention, Atlanta, GA, USA.
Andreas JahnMinistry of Health Malawi, Lilongwe, Malawi.
Kelsey MirkovicUS Centers for Disease Control and Prevention, Lilongwe, Malawi.
Rose NyirendaMinistry of Health Malawi, Lilongwe, Malawi.
MPHIA Study Team

Funding

CGH CDC HHS U2G GH001226Intramural CDC HHS CC999999PEPFAR
6 · The paper itself

Abstract

backgroundIn 2014, UNAIDS set the goal of ending the AIDS epidemic by 2030 through the achievement of testing and treatment cascade targets. To evaluate progress achieved and highlight persisting gaps in HIV epidemic control in Malawi, we aimed to compare key indicators (prevalence, incidence, viral load suppression, and UNAIDS 95-95-95 targets) from the 2015-16 and 2020-21 Malawi Population-based HIV Impact Assessment (PHIA) survey results.

methodsThe Malawi PHIAs were nationally representative, cross-sectional surveys with a two-stage cluster sampling design. The first survey was conducted between Nov 27, 2015, and Aug 26, 2016; the second survey was conducted between Jan 15, 2020, and April 26, 2021. Our analysis included survey participants aged 15-64 years. Participants were interviewed and a 14 mL blood sample was collected and tested for HIV infection using the national rapid testing algorithm. For each survey, we estimated key HIV epidemic indicators and achievement of 95-95-95 targets. The risk ratio (RR) of the indicators between surveys were computed and considered significant at a confidence level of 0·05. All results were weighted, and self-reported awareness and treatment status were adjusted to account for detection of antiretrovirals.

findingsOur analysis included 17 187 participants aged 15-64 years in 2015-16 and 21 208 in 2020-21 who participated in the surveys and blood draw. In the 2020-21 survey, 88·4% (95% CI 86·7-90·0) of people living with HIV were aware of their HIV-positive status; of those aware, 97·8% (97·1-98·5) were on antiretroviral therapy; and of those on treatment, 96·9% (95·9-97·7) were virally suppressed. Between surveys, the national HIV prevalence decreased significantly from 10·6% (10·0-11·2) to 8·9% (8·4-9·5) with RR 0·85 (95% CI 0·78-0·92; p<0·0001). The annual HIV incidence decreased from 0·37% (0·20-0·53) to 0·22% (0·11-0·34) with RR 0·61 (95% CI 0·31-1·20; p=0·15). The population viral load suppression increased from 68·3% (66·0-70·7) in 2015-16 to 87·0% (85·3-88·5) in 2020-21 (RR 1·27 [95% CI 1·22-1·32]; p<0·0001).

interpretationThese results suggest that Malawi had already surpassed the UNAIDS viral load suppression target for 2030 (85·7%) by 2020-21. Through strategies and evidence-informed interventions implemented in the last half decade, especially scale-up of effective HIV treatment, Malawi has made tremendous progress, including decreasing HIV prevalence and incidence and achieving both the second and third 95 targets ahead of 2030. To address the first 95, efforts in HIV diagnosis should focus on males and younger age groups. There is a continued need for effective linkage to care, retention on antiretroviral therapy, and adherence support to maintain and build on progress.

fundingUS President's Emergency Plan for AIDS Relief through the US Centers for Disease Control and Prevention.

Indexed as

Acquired Immunodeficiency SyndromeHIV InfectionsCross-Sectional StudiesHumansIncidenceMalawiMalePrevalenceViral Load

Identifiers

PMID37586390
PMCPMC10542580

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.